I thought they set it up to help with compassionate care cases.
Take a look at what they said in the press release—it’s not just about compassionate care cases. They’ve recognized the need due to not having their own leukapheresis unit, so while they wait, they’re also working to put this in place, which will be very useful in the long run.
This strategic investment has arisen out of the Company’s experience in its compassionate use program. The Company has found that it can often be difficult to obtain a timely leukapheresis appointment slot, due to general shortage of leukapheresis capacity in the UK. Patients may have to wait extended periods for a leukapheresis appointment, and their clinical condition may decline while waiting for a slot.
Market Data 
Markets 
AI
